Australian clinicians and chemoprevention for women at high familial risk for breast cancer

被引：0
|
作者：
Louise A Keogh
John L Hopper
Doreen Rosenthal
Kelly-Anne Phillips
机构：
[1] University of Melbourne,Key Centre for Women's Health in Society, School of Population Health
[2] University of Melbourne,Centre for MEGA Epidemiology, School of Population Health
[3] Peter MacCallum Cancer Centre,Division of Haematology and Medical Oncology
[4] The University of Melbourne,Department of Medicine, St Vincent's Hospital
来源：
Hereditary Cancer in Clinical Practice | / 7卷
关键词：
Breast Cancer; Tamoxifen; Mutation Carrier; Raloxifene; BRCA2 Mutation Carrier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Australian clinicians and chemoprevention for women at high familial risk for breast cancer
    Keogh, Louise A.
    Hopper, John L.
    Rosenthal, Doreen
    Phillips, Kelly-Anne
    [J]. HEREDITARY CANCER IN CLINICAL PRACTICE, 2009, 7
  • [2] Australian clinicians and chemoprevention for women at high familial risk for breast cancer
    Keogh, L. A.
    Philips, K.
    Rosenthal, D.
    Hopper, J. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians
    Macdonald, Courtney
    Saunders, Christobel M.
    Keogh, Louise A.
    Hunter, Morgan
    Mazza, Danielle
    Mclachlan, Sue-Anne
    Jones, Sandra C.
    Nesci, Stephanie
    Friedlander, Michael L.
    Hopper, John L.
    Emery, Jon D.
    Hickey, Martha
    Milne, Roger L.
    Phillips, Kelly-Anne
    [J]. CANCER PREVENTION RESEARCH, 2021, 14 (01) : 131 - 144
  • [4] Chemoprevention for breast cancer: A survey of the views of Australian women and clinicians
    Macdonald, C.
    Mazza, D.
    Hunter, M.
    Keogh, L. A.
    Milne, R.
    Hickey, M.
    Saunders, C.
    McLachlan, S. A.
    Friedlander, M.
    Hopper, J.
    Emery, J.
    Jones, S.
    Phillips, K. A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S8 - S8
  • [5] Chemoprevention of breast cancer for women at high risk
    Chan, Kathryn
    Morris, Gloria J.
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (06) : 642 - 646
  • [6] Acceptance of Chemoprevention by Women at High Risk for Breast Cancer
    Lane, Karen
    Hyunh, Kelly
    Smith, Edie
    Hsiang, David
    Butler, John
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : S180 - S180
  • [7] The experience of women at high risk for breast cancer receiving chemoprevention
    Whisenant, Meagan
    Jones, Jessica Trevino
    Brassil, Kelly
    Williams, Loretta A.
    Ponce, Darcy
    Kamat, Sharvari
    Solis, Emily
    Maliackal, Ann
    Walters, Amie
    Warlick, Hannah
    [J]. QUALITY OF LIFE RESEARCH, 2022, 31 : S74 - S75
  • [8] Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer
    Meiser, B
    Butow, P
    Price, M
    Bennett, B
    Berry, G
    Tucker, K
    Cuningham, K
    [J]. JOURNAL OF WOMENS HEALTH, 2003, 12 (08) : 769 - 778
  • [9] Chemoprevention or mastectomy for women at high risk of developing breast cancer
    Sismondi, Piero
    D'Alonzo, Marta
    Pecchio, Silvia
    Bounous, Valentina Elisabetta
    Robba, Elisabetta
    Biglia, Nicoletta
    [J]. MATURITAS, 2015, 82 (03) : 271 - 273
  • [10] Screening of women at high familial risk of breast cancer
    Narod, Steven A.
    [J]. WOMENS HEALTH, 2010, 6 (04) : 509 - 510
12345